1175297

Michael T. Lin, M.D. — FEI 3021744401

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756221 CFR 312.60Informed consent